1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Beverages - Alcoholic
Kirin Holdings Company, Limited

Kirin Holdings Company, Limited

KNBWF
Kirin Holdings Company, LimitedUS flagOther OTC
18.56
USD
- -
- -
14.81BMarket Cap
Kirin Holdings Company, Limited
KNBWF
(Other OTC)

Recent

price

18.56

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2,283.06
2,154.05
2,273.32
2,389.02
2,390.59
2,407.49
2,031.66
2,042.27
2,158.2
2,213.48
2,200.03
2,185.34
2,421
2,635.53
2,886.93
3,003.87
2,790.49
Revenue per Share
11.94
7.7
58.44
90.76
35.27
-51.87
163.19
265.17
183.57
68
85.57
71.73
135.09
139.16
71.87
182.13
170.3
Basic EPS, GAAP
116.76
121.61
117.59
93.38
37.85
102.89
145.6
145.61
123.16
93.99
85.42
159.52
45.13
110.39
76.87
- -
160.29
Free Cash Flow per Basic Share
23.98
26
27
33.82
37.1
38
38
40.5
50.11
58.57
65.81
65
65.44
71
72
- -
71
Dividend per Share
968.2
939.8
934.61
1,009.36
1,034.74
709.84
766.76
989.31
1,156.88
1,209
1,288.17
1,319.94
1,418.75
1,519.52
1,522.21
1,608.66
1,552.91
Book Value per Share
524.88
240.83
345.18
491.44
529.5
525.5
545.99
849.42
857.8
848.33
762.4
824.7
928.23
903.53
460.1
453.24
925.25
Tangible Book Value per Share
954
962
962
944
919
913
913
913
895
877
841
834
822
810
810
810
810
Basic Weighted Avg Shares
2,177,802
2,071,774
2,186,177
2,254,585
2,195,795
2,196,925
1,853,937
1,863,730
1,930,522
1,941,305
1,849,545
1,821,570
1,989,468
2,134,393
2,338,385
2,433,363
2,259,985
Sales/Revenue/Turnover
6.96
6.9
7
6.33
5.22
5.68
10.6
11.32
10.27
4.52
5.56
3.74
5.83
7.04
5.36
8.62
8.6
Operating Margin (%)
139,987
142,762
146,362
149,036
148,600
121,926
71,615
68,942
67,946
80,742
82,109
81,130
85,937
87,227
95,702
- -
90,163
Depreciation Expense
11,394
7,407
56,198
85,656
32,392
-47,329
148,918
241,991
164,202
59,642
71,935
59,790
111,007
112,697
58,214
147,542
137,926
Net Income, GAAP
71.98
72.62
45.01
33.88
42.4
263.53
24.05
22.23
20.92
30.29
19.84
31.31
24.88
23.65
38.58
25.09
26.42
Effective Tax Rate (%)
0.52
0.36
2.57
3.8
1.48
-2.15
8.03
12.98
8.51
3.07
3.89
3.28
5.58
5.28
2.49
6.06
6.1
Profit Margin (%)
47,393
42,646
71,359
154,890
17,159
116,020
83,047
259,261
241,809
74,769
129,067
227,667
254,326
285,015
297,128
291,940
300,235
Working Capital
582,790
834,486
768,584
642,667
569,000
598,943
511,536
362,622
317,937
291,207
393,610
449,970
408,662
555,725
779,583
842,434
605,972
LT Debt
1,159,036
1,047,893
1,153,899
1,300,724
1,335,708
938,081
959,188
1,218,473
1,191,418
1,146,825
1,095,939
1,147,990
1,253,203
1,425,838
1,533,714
1,595,147
1,588,298
Total Equity
1.99
1.82
3.76
4.25
2.97
-10.11
8.67
9.77
9.4
3.68
4.78
2.7
4.98
5.93
3.43
6.36
6.71
Return on Invested Capital (%)
0.33
-0.13
2.43
4.04
1.72
-5.4
8.4
13.77
8.26
2.49
2.67
2.88
4.3
4.01
1.8
5.25
4.72
Return on Capital (%)
1.21
0.81
6.23
9.25
3.4
-5.92
22.1
30.2
16.95
5.69
6.71
5.48
9.8
9.41
4.73
11.64
11.36
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
100,673
131,573
121,301
LT Borrowings
555,725
625,896
605,972
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
810
810
810
Market Capitalization
1,654,664
1,741,647
1,727,466

Working Capital

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
957,821
977,905
1,017,684
Cash, Cash Equivalents & STI
140,343
160,145
146,280
Accounts Receivable, Net
444,940
403,817
439,632
Inventories
330,984
353,116
375,785
Total Current Liabilities
672,806
693,399
717,449
Payables & Accruals
- -
- -
- -
ST Debt
100,673
131,573
121,301
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.81%
7.85%
4.01%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-25.2%
35.08%
153.45%
Sales/Revenue/Turnover
1.29%
5.72%
4.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
501,762
594,061
- -
- -
2,338,385
2025
- -
- -
- -
- -
2,433,363
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
31.98
38.67
- -
- -
71.87
2025
- -
- -
- -
- -
182.13
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36.5
- -
- -
- -
72
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
San Miguel Brewery HK Ltd. (SMGLF)
Compañía Cervecerías Unidas S.A. (CCU)
Compagnia dei Caraibi S.p.A. (1TIME.MI)
Carlsberg A/S (CARL-A.CO)
Fomento Económico Mexicano, S.A.B. de C.V. (FEMSAUBD.MX)
China Tontine Wines Group Limited (0389.HK)
Business
Kirin Holdings Company, Limited, a holding company incorporated on February 23, 1907 and headquartered at Nakano Central Park South, 10-2 Nakano 4-chome, Nakano-ku, Tokyo, Japan, develops group-wide management strategies and oversees implementation across its Food & Beverages, Pharmaceuticals, and Health Science domains; core offerings encompass beer brands including Kirin Lager Beer, Ichiban Shibori, and craft beers; spirits, wine, hard liquor, and non-alcoholic beverages such as tea, fruit juices, and soft drinks; food products; pharmaceuticals leveraging fermentation and biotechnology; and health science products focused on beauty, wellness, and supplements through subsidiaries like FANCL and Blackmores. The company operates globally with significant presence in Japan, Southeast Asia including the Philippines via a 48% stake in San Miguel Brewery, Oceania through Blackmores in Australia, the United States, and other regions, targeting consumers and businesses with its diversified portfolio driven by R&D in bioprocess technology, future beverages, and packaging innovation. In recent developments, Kirin completed a tender offer in September 2024 to acquire additional shares in FANCL, elevating its ownership to 75.24% and positioning FANCL as a consolidated subsidiary by late September 2024 following a reverse stock split, with full consolidation aimed to accelerate synergies across Kirin, FANCL, and Blackmores to establish one of Asia-Pacific's largest health science companies; the group also pursues its Kirin Group Vision 2027 for CSV leadership from Food & Beverages to Pharmaceuticals, reports consolidated revenue of 2,338,385 million yen for fiscal year ended December 31, 2024, and advances sustainability initiatives like Rainforest Alliance Certification for black tea supply chains.